TP53 and cancer: On its part, EZH2 transcriptionally represses the cell cycle suppressor INK-ARF, driving cell cycle progression of cancer stem cells [61], so p53 mutants could induce cell cycle progression by inducing Cyclin E2 and CDK2 expression and silencing INK-ARF expression through negative regulation of miR-101-3p.